Boston Scientific has closed on its $615 million acquisition of gastroenterology device company Apollo Endosurgery.
Boston Scientific announced its plan to acquire the company for $10 per share in November.
Apollo’s main focus is on the design, development and commercialization of less invasive gastrointestinal and endoscopic devices.
This acquisition will mark Boston Scientific’s entry into the endobariatric market, according to an April 4 news release shared with Becker’s.
Nanosonics has received FDA De Novo clearance for its new Coris system, a technology designed to improve the cleaning of…
Gastrointestinal procedures make up a huge share of the most commonly billed services at ASCs, according to a March 13…
The number of Medicare-certified, single-specialty gastroenterology ASCs grew by 122 nationwide from 2018 to 2023, according to data from a…
Comments are closed.